The Franklin County Board of Commissioners has passed a resolution urging the Benton Franklin Health District (BFHD) to cease providing, funding, and promoting gene-therapy vaccines until ...
US aid freeze affects HIV and malaria supply chains, FDA postpones rare disease events, and a leap in Texas measles cases. Meanwhile, Mirum Pharma's drug gets FDA approval, Eli Lilly invests in a ...
One of the largest pharmaceutical companies in North Carolina is discontinuing a treatment produced in the state.
According to multiple media reports on Thursday, Pfizer Inc. (NYSE:PFE) has terminated the global development and ...
Pfizer’s decision to halt further marketing of Beqvez is further sign of the sparse patient interest in gene therapies for the bleeding condition.
Ixinity (trenonacog alfa) can effectively prevent and controlled bleeds in young children with severe or moderately severe ...
Columnist Jennifer Lynne stresses the significance of hidden symptoms in the lives of those with bleeding disorders.
Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez. | ...
The move comes weeks after Pfizer terminated its partnership with Sangamo Therapeutics for another hemophilia gene therapy.
Pfizer said on Thursday it will stop global development and commercialization of its hemophilia gene therapy, Beqvez, citing ...
Medpage Today on MSN1d
Pfizer to Discontinue Its Hemophilia B Gene TherapyLess than a year after approval, Pfizer said it plans to discontinue its hemophilia B gene therapy fidanacogene elaparvovec ...
Pfizer said on Thursday it will end global development of its hemophilia gene therapy, Beqvez, citing soft demand from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback